This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Early Winners & Losers

Wireless Facilities (WFII) tumbled 14.8% in after-hours trading Monday after announcing that there's a "strong likelihood" it will need to restate results from 1998 through 2003, based on preliminary findings from an ongoing internal stock-option grant review. The San Diego-based firm will delay filing its year-end 2006 financials until the review is finished. Shares of the wireless-communications services firm were falling 31 cents to $1.79 in recent extended trading.

TransAct Technologies (TACT - Get Report) dropped after Chief Executive Bart Shuldman issued a nonspecific "cautious outlook" for the coming year, citing decelerating slot-machine orders from casinos. The company blames this on "anticipation of the expected upgrade cycle for server-based gaming," and additionally believes that pending casino privatizations may contribute to the slowdown.

Despite swinging to a fourth-quarter profit that beat expectations, the Wallingford, Conn.-based small-cap was losing $1.02, or 10.9%, to $8.37.

Panacos Pharma (PANC) declined after announcing a more cautious phase IIb study of bevirimat for HIV treatment, the first cohort of which yielded disappointing results due to poor drug delivery. The next few cohorts will go back to the oral-liquid formulation used in the phase IIa studies and test fewer patients for shorter amounts of time (14 days) with increasing dosages.

When the optimal dosage is determined, Panacos will conduct extended-dose cohorts. Panacos expects pivotal trials of the drug to begin sometime in 2008. Shares of the Watertown, Mass., company were off 46 cents, or 10.8%, to $3.79.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
PANC $0.00 0.00%
GAIA $6.40 0.00%
TACT $9.99 0.00%
TXN $50.46 0.00%
XXIA $15.28 0.00%


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs